Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 200,000 shares at $46.89 ($9.4M) on 2021-03-02, disclosed to the SEC on 2021-03-04.
Open-market sale of $9.4M RPRX by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.89 | 94,978 | $4.5M | 47.4% |
| 2 | $46.89 | 94,978 | $4.5M | 47.4% |
| 3 | $47.88 | 5,022 | $240K | 2.6% |
| 4 | $47.88 | 5,022 | $240K | 2.6% |
| Total | $46.94 avg | 200,000 | $9.4M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |